> The official news feed of OCPInfo.com - The Ontario College of Pharmacists en-us OCPInfo.com Copyright 2012 http://www.ocpinfo.com 08 Feb 2012 00:00 -0500 OcpinfocomNewsFeedhttp://feedburner.google.comSubscribe with My Yahoo!Subscribe with NewsGatorSubscribe with My AOLSubscribe with BloglinesSubscribe with NetvibesSubscribe with GoogleSubscribe with PageflakesSubscribe with PlusmoSubscribe with The Free DictionarySubscribe with Bitty BrowserSubscribe with NewsAlloySubscribe with Live.comSubscribe with Excite MIXSubscribe with Attensa for OutlookSubscribe with WebwagSubscribe with Podcast ReadySubscribe with FlurrySubscribe with WikioSubscribe with Daily Rotation 08 Feb 2012 00:01 -0500Health Canada is concerned about Canadian and international adverse events associated with non-invasive ventilation devices being used as life-supporting ventilators. One reported Canadian case resulted in the patient requiring resuscitation. Click here for more information.http://www.ocpinfo.com/client/ocp/ocphome.nsf/OCPRSSView/FE5C3B383A2182C88525799E00592854http://www.ocpinfo.com/client/ocp/ocphome.nsf/OCPRSSView/FE5C3B383A2182C88525799E00592854 06 Feb 2012 14:34 -0500Apr 25, 2012 This one-day workshop begins with an overview of the system approach in the management of error and introduction to human factors engineering principles. Root cause analysis (RCA) is a tool to help investigate adverse events and critical incidents in healthcare, identify and analyze root causes and contributing factors, and develop recommendations. Procedures on how to conduct an RCA will be demonstrated through interactive exercises and group work. The facilitator will go through causal statements, actions, and outcome measurement used in RCA. Participants will also learn about diagramming and identification of contributing factors through case studies in pharmacy practice. http://www.ismp-canada.org/education/rcaworkshops/20120425_Toronto/APRIL_25_RCA. pdfhttp://www.ocpinfo.com/client/ocp/ocphome.nsf/OCPRSSView/226325D773EB1EA88525799C006B7E7Ahttp://www.ocpinfo.com/client/ocp/ocphome.nsf/OCPRSSView/226325D773EB1EA88525799C006B7E7A 06 Feb 2012 14:32 -0500Mar 20-21 The workshop is designed for those working in healthcare in both clinical and non-clinical areas, including: Directors of Care, Risk Management Officers, Patient Safety Officers, Physicians, Nurses, Pharmacy Directors, Pharmacists, Pharmacy Technicians, Staff Educators, Quality Managers, Allied Healthcare Professionals, Food Services Personnel, Maintenance Staff and others who want to be involved in initiatives to improve patient safety. http://www.ismp-canada.org/education/workshops/2012/20120320_RCA-FMEA_Vancouver/ index.phphttp://www.ocpinfo.com/client/ocp/ocphome.nsf/OCPRSSView/6C267ADA4EE5A4B18525799C006B61AChttp://www.ocpinfo.com/client/ocp/ocphome.nsf/OCPRSSView/6C267ADA4EE5A4B18525799C006B61AC 06 Feb 2012 14:31 -0500March 7-8, 2012 The workshop is designed for those working in healthcare in both clinical and non-clinical areas, including: Directors of Care, Risk Management Officers, Patient Safety Officers, Physicians, Nurses, Pharmacy Directors, Pharmacists, Pharmacy Technicians, Staff Educators, Quality Managers, Allied Healthcare Professionals, Food Services Personnel, Maintenance Staff and others who want to be involved in initiatives to improve patient safety. http://www.ismp-canada.org/education/workshops/2012/20120307_RCA-FMEA_Halifax/in dex.phpHalifaxhttp://www.ocpinfo.com/client/ocp/ocphome.nsf/OCPRSSView/192E255AB95368948525799C006B3B10http://www.ocpinfo.com/client/ocp/ocphome.nsf/OCPRSSView/192E255AB95368948525799C006B3B10 06 Feb 2012 14:28 -0500March 6-7, 2012 The workshop is designed for those working in healthcare in both clinical and non-clinical areas, including: Directors of Care, Risk Management Officers, Patient Safety Officers, Physicians, Nurses, Pharmacy Directors, Pharmacists, Pharmacy Technicians, Staff Educators, Quality Managers, Allied Healthcare Professionals, Food Services Personnel, Maintenance Staff and others who want to be involved in initiatives to improve patient safety. http://www.ismp-canada.org/education/workshops/2012/20120306_RCA-FMEA_Toronto/in dex.php http://www.ocpinfo.com/client/ocp/ocphome.nsf/OCPRSSView/5D797540D61FE7CB8525799C006AFF12http://www.ocpinfo.com/client/ocp/ocphome.nsf/OCPRSSView/5D797540D61FE7CB8525799C006AFF12 06 Feb 2012 13:34 -0500March 22, 2012 Webcast: 12:00-2:00pm (EST) The Canadian Adverse Events Study, published in 2004, found that 7.5% of people admitted to hospitals in Canada experienced at least one adverse event and that almost 21% of such adverse events were fatal. The Office of the Chief Coroner for Ontario serves the living through high quality death investigations and inquests to ensure that no death will be overlooked, concealed or ignored. The findings are used to generate recommendations to help improve public safety and prevent deaths in similar circumstances. The Patient Safety Review Committee (PSRC) assists the Office of the Chief Coroner in the investigation, review and development of recommendations towards the prevention of deaths regarding health care-related cases where system-based errors appear to be a major factor. The PSRC also assists coroners in improving the investigation of deaths within, or arising from, the health care system in which system-based errors appear to have occurred.This webcast will feature the PSRC findings and recommendations on narcotic medication use in hospitals. Because of the frequency of their use, it is easy for providers to lose sight of the fact that these medicationscarry with them significant, and even fatal, side effects.This session will be case-based, and will focus on common sources of narcotic medication error, from prescribing to dispensing to administration to monitoring. Through exploration of these cases, the participant will gain an understanding of the underlying contributing actors and system-based strategies to prevent narcotic medication errors and serious side effects of narcotic administration. http://www.oha.com/Education/Pages/CalendarofEventDetails.aspx?eventid=DL529http://www.ocpinfo.com/client/ocp/ocphome.nsf/OCPRSSView/964E2C2F7C381D608525799C006611DAhttp://www.ocpinfo.com/client/ocp/ocphome.nsf/OCPRSSView/964E2C2F7C381D608525799C006611DA 06 Feb 2012 13:31 -0500Wednesday, February 29, 2012 (at 12 noon EST) . This one hour webinar will address how patient safety culture is measured so participants have a sense of what culture measures can and cannot achieve. Suggestions for ways to start the culture conversation in an organization or with a team will be provided. Recent data from newly graduated health professionals in medicine, nursing and pharmacy on their perceived patient safety cultural competency will also be shared to highlight the complexities involved with fostering such a culture in healthcare organizations. http://www.ismp-canada.org/education/webinars/20120229_Patient_Safety_Culture/ Medication Safety- Measuring Patient Safety Culture - Can we reveal the Intangible?http://www.ocpinfo.com/client/ocp/ocphome.nsf/OCPRSSView/E73C78537769A75C8525799C0065C180http://www.ocpinfo.com/client/ocp/ocphome.nsf/OCPRSSView/E73C78537769A75C8525799C0065C180 06 Feb 2012 13:29 -0500Wednesday, February 15, 2012 (at 12 noon EST). This one hour webinar is designed to introduce frontline healthcare workers to the fundamental improvement theory and tools in widespread use throughout the industry. The content speaks to the challenge of creating positive and sustainable change in any healthcare setting. Tools and resources that facilitate the creation of safer systems of care for general patient populations will be shared. http://www.ismp-canada.org/education/webinars/20120215_Quality_Improvement/http://www.ocpinfo.com/client/ocp/ocphome.nsf/OCPRSSView/4173B753C33B325A8525799C006591D6http://www.ocpinfo.com/client/ocp/ocphome.nsf/OCPRSSView/4173B753C33B325A8525799C006591D6 06 Feb 2012 13:27 -0500Thursday, February 9, 2012 at 1:30 pm EST. This one hour interactive webinar is designed to provide healthcare professionals and administrators with an overview of an ISMP Canada initiative to assess knowledge deficits amongst healthcare providers related to the safe and effective use of Hydromorphone. http://www.ismp-canada.org/education/webinars/20120209_Hydromorphone/index.phphttp://www.ocpinfo.com/client/ocp/ocphome.nsf/OCPRSSView/5C7D837CBC03F0998525799C00655B5Ehttp://www.ocpinfo.com/client/ocp/ocphome.nsf/OCPRSSView/5C7D837CBC03F0998525799C00655B5E 31 Jan 2012 00:01 -0500Janssen Inc., in consultation with Health Canada, would like to alert you to the risk of fatal outcome associated with the inadvertent intrathecal administration of the antineoplastic drug VELCADEŽ (bortezomib). Click here for more information.http://www.ocpinfo.com/client/ocp/ocphome.nsf/OCPRSSView/0A15D65FD014CAEC8525799600552F94http://www.ocpinfo.com/client/ocp/ocphome.nsf/OCPRSSView/0A15D65FD014CAEC8525799600552F94 31 Jan 2012 00:01 -0500The product monograph for Doribax will be updated to reflect findings from a study showing a higher mortality rate and a lower cure rate among patients taking Doribax 1g every 8 hours in a fixed 7-day course as compared to those taking a fixed 10-day course of imipenem-cilastatin - Janssen Inc. Click here for more information.http://www.ocpinfo.com/client/ocp/ocphome.nsf/OCPRSSView/711D431E6D09C3F985257996006D1831http://www.ocpinfo.com/client/ocp/ocphome.nsf/OCPRSSView/711D431E6D09C3F985257996006D1831 30 Jan 2012 17:14 -0500When: April 15 - 17, 2012 Where: Westin Ottawa Web: http://www.cadth.ca/en/events/2012-cadth-symposium/program http://www.ocpinfo.com/client/ocp/ocphome.nsf/OCPRSSView/4FCB759025EBC59985257995007A2A3Bhttp://www.ocpinfo.com/client/ocp/ocphome.nsf/OCPRSSView/4FCB759025EBC59985257995007A2A3B 30 Jan 2012 15:20 -0500February 15 and February 16, 2012, 9:00am - 4:00pm at St. Leonards Place Peel, 1105 Queen Street East, Brampton, Ontario. This training is designed to help clients navigate addiction treatment in Ontario using the Admission and Discharge Criteria and Standardized Tools. For further information, please contact Gary Hoskins at 416-535-8501, ext. 7718 or Gary_Hoskins@camh.net or Mary Austin at 416-535-8501, ext. 6028 or Mary_Austin@camh.net. Please call or email Mary Austin for registration information.http://www.ocpinfo.com/client/ocp/ocphome.nsf/OCPRSSView/2C4575E7FE61481885257995006FC19Bhttp://www.ocpinfo.com/client/ocp/ocphome.nsf/OCPRSSView/2C4575E7FE61481885257995006FC19B 30 Jan 2012 15:18 -0500March 7, 2012, 7:00pm - 8:30pm (EST), and repeated again on March 8, 2012, 9:00am - 10:30am (EST), WEBINAR Faculty: Eva Janecek (CAMH). This free webinar event is for Pharmacists in Ontario who want to increase their knowledge about opioid substitution therapy. The Webinar is designed for pharmacists who offer methadone/buprenorphine services; however, any pharmacist is welcome to participate. For further information, please contact Sylvie Guenther, Sylvie_Guenther@camh.net. COST: FREE Please Registerhttp://www.ocpinfo.com/client/ocp/ocphome.nsf/OCPRSSView/A31A35F6C32B497285257995006F8E0Chttp://www.ocpinfo.com/client/ocp/ocphome.nsf/OCPRSSView/A31A35F6C32B497285257995006F8E0C 30 Jan 2012 15:15 -0500February 22, 2012, 9:00am - 10:30am (EST), and repeated again on February 23, 2012, 7:00pm - 8:30pm (EST), WEBINAR Faculty: Eva Janecek (CAMH). This free webinar event is for Pharmacists in Ontario who want to increase their knowledge about opioid substitution therapy. The Webinar is designed for pharmacists who offer methadone/buprenorphine services; however, any pharmacist is welcome to participate. For further information, please contact Sylvie Guenther, Sylvie_Guenther@camh.net. COST: FREE Please Register http://www.ocpinfo.com/client/ocp/ocphome.nsf/OCPRSSView/251BFD222BD30A9D85257995006F517Ahttp://www.ocpinfo.com/client/ocp/ocphome.nsf/OCPRSSView/251BFD222BD30A9D85257995006F517A 30 Jan 2012 15:06 -0500February 16, February 21 and February 27 This live webinar will review the use of methadone in the treatment of addictions in the First Nations population. Presented by Dr. Sandra Sas, a methadone practitioner, this program will examine some of the issues pharmacists may face when working with First Nations patients: servicing rural or remote areas, anonymity and privacy, access to care, and cultural and social considerations. This program will also help identify ways to overcome barriers to methadone treatment in First Nations patients. Webinars begin at 7 p.m. To register, visit https://dircevents.webex.com/dircevents/onstage/g.php?p=9andt=m This complimentary program is made available through funding from the Ministry of Health and Long-Term Care. Please note that the Methadone Treatment in Special Populations: First Nations webinar does not replace the Centre for Addiction and Mental Health Opioid Dependence Treatment course which Designated Managers and pharmacists are required to complete in order to dispense methadone, as outlined in the OCP Methadone Maintenance Treatment and Dispensing Policy.http://www.ocpinfo.com/client/ocp/ocphome.nsf/OCPRSSView/3ED56B2C4B8C19F985257995006E809Fhttp://www.ocpinfo.com/client/ocp/ocphome.nsf/OCPRSSView/3ED56B2C4B8C19F985257995006E809F 30 Jan 2012 00:01 -0500Maximum doses for the antidepressant Celexa (citalopram) have been decreased and the product monograph has been updated accordingly given new cardiac safety data showing an increased risk of QT prolongation and abnormal heart rhythms at high doses. Click here for more information.http://www.ocpinfo.com/client/ocp/ocphome.nsf/OCPRSSView/BC32395D6FF69F9385257995006C56ABhttp://www.ocpinfo.com/client/ocp/ocphome.nsf/OCPRSSView/BC32395D6FF69F9385257995006C56AB 26 Jan 2012 00:01 -0500Health Canada is advising Canadians not to use these foreign health products as they may pose a health risk. These products have been found by regulators in other countries to contain prescription, over-the-counter or unauthorized drugs, or heavy metals that are not declared on the product labels. Prescription drugs should only be taken under the supervision of a health care practitioner. These products are not authorized for sale in Canada and have not been found on the Canadian market, but they may have been brought into the country by travellers or purchased over the Internet. 17 weight loss products (see Alert for a complete list), the U.S. Food and Drug Administration warned that these weight loss products contain unauthorized drugs (sibutramine, phenolphthalein) Uprizing 2.0, the U.S. Food and Drug Administration warned that this body building product contains a controlled prescription drug (superdrol). Get Stiff, Maxi Mize, New Zealand’s Medsafe warned that these sexual enhancement products contain prescription drugs (tadalafil, vardenafil, yohimbine) and/or unauthorized drugs (hydroxyhomosildenafil, hydroxythiohomosildenafil). Ying Da Wang tablets, the Australian Therapeutic Goods Administration warned that this sexual enhancement product contains a prescription drug (sildenafil). Slimina weightloss capsules (S-shape slim capsules), the Australian Therapeutic Goods Administration warned that these weight loss products contain prescription drugs (propranolol, nifedipine) and/or unauthorized drugs (sibutramine, fenfluramine, phenolphthalein). Athri-Eze, Sear Heang Tienchi Tu Chung Wan, Wiku Jahe Kencur (Akur Mujarab), Cap Wijaya Kusuma (An Ki It). The Singapore Health Sciences Authority warned that these Traditional Chinese or Traditional Malay Jamu products contain prescription and/or over-the-counter drugs (dexamethasone, prednisolone, furosemide, allopurinol, acetaminophen, chlorpheniramine), and/or an unauthorized drug (phenylbutazone). Cardiotium, Paidusu, SlimEasy Herbs Capsule, Tianran Zuanshi Xianweisu. The Hong Kong Department of Health warned that these health products contain prescription drugs (losartan, atorvastatin, thyroxine) and/or unauthorized drugs (sibutramine, phenolphthalein). Consult a health care practitioner immediately if you have taken “Cardiotium” while pregnant. The use of losartan during pregnancy can cause injury and even death to the fetus. [LuShenPai] Specific Hou Ton Qing, [AA] Pe Min Kan Wan - The Hong Kong Department of Health warned that these traditional Chinese health products contain excessive levels of heavy metals (arsenic or mercury). Click here for more information.http://www.ocpinfo.com/client/ocp/ocphome.nsf/OCPRSSView/47B2FD1EAFBF77E1852579910055B8EDhttp://www.ocpinfo.com/client/ocp/ocphome.nsf/OCPRSSView/47B2FD1EAFBF77E1852579910055B8ED 26 Jan 2012 00:01 -0500Covidien is conducting a voluntary recall of all production lots for the Duet TRS Universal Straight and Articulating Single Use Loading Units (SULU) with respect to the use of this product family in the thoracic cavity. Serious injuries and deaths have occurred due to the failure mode associated with this recall. Click here for more information.http://www.ocpinfo.com/client/ocp/ocphome.nsf/OCPRSSView/F627C7F565A575138525799100568714http://www.ocpinfo.com/client/ocp/ocphome.nsf/OCPRSSView/F627C7F565A575138525799100568714 24 Jan 2012 17:00 -0500Date: February 15, 2012 (12 pm to 1 pm EST) Register Now This one hour webinar is designed to introduce frontline healthcare workers to the fundamental improvement theory and tools in widespread use throughout the industry. The content speaks to the challenge of creating positive and sustainable change in any healthcare setting. Tools and resources that facilitate the creation of safer systems of care for general patient populations will be shared. Website: http://www.ismp-canada.org/education/webinars/20120215_Quality_Improvement/ Contact: webinars@ismp-canada.orghttp://www.ocpinfo.com/client/ocp/ocphome.nsf/OCPRSSView/C991FDB84C4C32D18525798F0078DE5Bhttp://www.ocpinfo.com/client/ocp/ocphome.nsf/OCPRSSView/C991FDB84C4C32D18525798F0078DE5B